Evolution of the Average Target: Vivendi SE

Data source: Vivendi SE(VIV)

Evolution of the Target Price: Vivendi SE

Data source: Vivendi SE(VIV)

Changes in Analyst Recommendations: Vivendi SE

Data source: Vivendi SE(VIV)
7682af5128348e9f60c57605c627bd8._mDhVTbBXvwVtGhT5tomJb9HK55xc6H_kYZL9JjayFA.yze1PHeREZ9Z2SYCnO5oFdMwBtEmPdK1qOUBusC7uzKGMq0Dc4cupULmGw~729ef3931a63ab7d07cb7fa013e26ecf
09-09 Deutsche Bank cuts its target on Vivendi Zonebourse
09-04 Volkswagen shifts into second gear, with Porsche in its wake. Vivendi disappoints Zonebourse
09-03 Vivendi: Mixed H1 '26 results with no deleveraging Alphavalue
07-10 Vivendi: EPS upgrade (2026: +343.0%, 2027: +1.6%) Alphavalue
05-29 Vivendi takeover unlikely to rest on an internal email Alphavalue
04-21 Vivendi: A difficult start to the year with limited highlights Alphavalue
04-10 Robertet follows its nose, Sodexo loses its appetite Zonebourse
04-07 Vivendi: UMG/Pershing Square: US listing disguised as a merger Alphavalue
03-24 AlphaValue/Baader Europe Cuts Vivendi EPS Forecasts on Net Income Miss; Price Target Up MT
03-23 Vivendi: Target upgrade by 11.5% Alphavalue
03-12 Vivendi: Continued good progress on cost cutting and deleveraging Alphavalue
11-28 Vivendi takeover prospects dim after French Supreme Court ruling Alphavalue
11-21 AlphaValue Downgrades Recommendation on Vivendi Shares Zonebourse
11-21 Vivendi Down to Reduce from Buy as AlphaValue/Baader Europe Says Bolloré Takeover Prospects 'Nil' MT
11-20 Vivendi faces reduced rating as takeover hopes fade Alphavalue
11-19 Vivendi share slide deepens as mandatory takeover prospects fade Alphavalue
25-10-22 Vivendi: Useless Q3 results Alphavalue
25-10-21 Vivendi nine months revenue at EUR 213 million RE
25-08-08 Update on Recommendation Changes in Paris RE
25-07-31 Vivendi: Good progress on cost cutting and deleveraging Alphavalue
25-07-29 Vivendi: New elements in the Bolloré/Vivendi saga Alphavalue
25-07-21 Vivendi: NAV cut by -2.9% Alphavalue
25-07-18 Vivendi: Increased likelihood of European Commission fine, but investment case remains appealing Alphavalue
25-07-18 A welcomed AMF decision that improves an already very appealing investment case Alphavalue
25-04-28 Vivendi: A good start to the year for Vivendi Alphavalue

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+26.96%
+21.58%
+17.04%
-5.59%
+2.87%
+6.33%
- -2.8%
Average +9.48%
Weighted average by Cap. +16.63%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
1.556EUR
Average target price
2.193EUR
Spread / Average Target
+40.93%
High Price Target
3.000EUR
Spread / Highest target
+92.80%
Low Price Target
1.800EUR
Spread / Lowest Target
+15.68%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
A
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!